VRCA

Verrica Pharmaceuticals Inc.

Price

$5.30

return (12m)

-4.50%

p/e

-3.28

p/bv

23.73

DIVIDEND YIELD

0.00%

VRCA price

Verrica Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VRCA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.09%

3 months

-7.99%

1 year

-4.50%

2 years

-77.25%

5 years

-95.21%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals VRCA

Valuation

P/E

-3.28

Sector -0.16

Industry 2.77

P/BV

23.73

Sector 1.93

Industry 2.37

P/Revenue (PSR)

3.37

Sector 1.67

Industry 1.97

EV/EBITDA

Sector -55.30

Industry -73.25

EV/EBIT

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

2.84

Sector 0.91

Industry 1.07

P/Net Current Assets

109.97

Sector -24.70

Industry -5.25

P/Working Capital

10.03

Sector -5.32

Industry 3.11

EPS

-1.48

Sector -0.79

Industry -0.61

BVPS

0.21

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

92.11%

Sector 48.28%

Industry 50.49%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.00%

Sector -62.93%

Industry -21.31%

Operating Margin

-93.60%

Sector -23.12%

Industry -27.36%

Net Profit Margins

-100.00%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.16

Sector 0.13

Industry 0.15

Profitability

ROE

-723.20%

Sector -31.93%

Industry -27.86%

ROA

-86.54%

Sector -28.25%

Industry -27.56%

ROIC

0.00%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.45

Sector 1.85

Industry 1.98

Net Debt / EBITDA

Sector -42.46

Industry -72.45

Net Debt / EBIT

Sector -37.26

Industry -7.11

Net Debt / Equity

0.00

Sector -1.04

Industry -0.12

Gross Debt / Equity

0.00

Sector -0.72

Industry 0.10

Equity/Assets

0.12

Sector 0.43

Industry 0.45

Liabilities/Assets

0.88

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

20.36%

Sector -

Industry -

5Y Earnings CAGR

-2.34%

Sector -

Industry -

Fundamentals VRCA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VRCA Verrica Pharmaceuticals Inc.	$5.30	-6.36%	0.00%	-3.28	23.73	-723.20%	-100.00%
LLY Eli Lilly and Compay	$1,169.97	61.21%	0.52%	41.58	-	-%	33.53%
SNY Sanofi	$44.84	-7.34%	3.87%	7.43	1.37	18.43%	13.81%
GSK GlaxoSmithKline PLC	$50.24	31.67%	3.42%	15.92	4.50	28.24%	14.54%
CRMD CorMedix Inc.	$8.22	-41.87%	0.00%	3.45	1.40	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$21.77	-28.60%	0.00%	12.05	1.23	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.12	-14.31%	0.68%	27.69	2.50	9.03%	10.14%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
NVS Novartis AG	$153.04	22.95%	1.96%	28.21	7.75	27.47%	26.57%
TMO Thermo Fisher Scientific Inc.	$618.91	27.34%	0.29%	33.36	4.42	13.26%	15.08%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
DHR Danaher Corporation	$215.43	5.71%	0.67%	37.88	2.88	7.61%	15.95%
HCA HCA Healthcare Inc.	$419.06	4.14%	0.70%	12.08	-29.56	-244.72%	10.07%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$26.71	0.25%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$327.50	-15.63%	1.06%	33.67	5.23	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VRCA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2018

Time since IPO - 8 years

29

Employees

Verrica Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $102.27 million, with shareholders equity totaling $4.31 million.

The company employs approximately 29 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Verrica Pharmaceuticals Inc. reported $30.31 million in revenue, generating net income of $-31.17 million.

Key financial metrics include a P/E ratio of -3.28, a price-to-book (P/B) ratio of 23.73, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VRCA.

Market cap

$102.27 million

Net worth

$4.31 million

$4,310,000.00

Assets

$36.02 million

$36,020,000.00

Total Shares Outstanding

21.00 million

21,000,000

Average Daily Trading Volume

$49.41 Thousand

$49,410.68

Sector

Health

Industry

Pharmaceutical Products

VRCA

VRCA revenue and profits

Financial Results VRCA

DRAG THE FRAME TO SEE MORE DATA

VRCA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75